<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="61145">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02309931</url>
  </required_header>
  <id_info>
    <org_study_id>CCR-HCUVA-2014-01</org_study_id>
    <nct_id>NCT02309931</nct_id>
  </id_info>
  <brief_title>ISOperistaltic Versus ANTIperistaltic Anastomosis After Laparoscopic Right Colectomy for Cancer</brief_title>
  <acronym>ISOVANTI</acronym>
  <official_title>Randomized Clinical Trial Comparing Isoperistaltic Versus Antiperistaltic Side to Side Anastomosis After Right Laparoscopic Hemicolectomy for Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Virgen de la Arrixaca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Virgen de la Arrixaca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will provide a precise control compared to the two interventions (iso vs
      antiperistaltic anastomoses) with thorough measurements of the postoperative variables and
      complications to improve the evaluation of the surgical technique. It will also enable an
      evaluation of the quality of life after the procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>within the first 30 days up to one year after surgery</time_frame>
    <description>Number of patients with postoperative complications and grade of Clavien-Dindo</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operating time</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomosis time</measure>
    <time_frame>From the enteromy to its closure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of say</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first tolerance day</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 days</time_frame>
    <description>First day taking liquids without vomits or abdominal distension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first flatus day</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first faeces day</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Orocecal transit</measure>
    <time_frame>up to one year</time_frame>
    <description>Using hydrogen breath test curves. preoperative, at day 2 postoperative, 1 month, 6 months and 1 year.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal life quality</measure>
    <time_frame>up to one year</time_frame>
    <description>Using gastrointestinal quality life index questionnaire. preoperative, 1 month, 6 months and 1 year.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Primary Malignant Neoplasm of Ascending Colon</condition>
  <arm_group>
    <arm_group_label>Isoperistaltic anastomosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with right colon cancer who undergo a right laparoscopic hemicolectomy and a isoperistaltic side-to-side ileocecal anastomosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antiperistaltic anastomosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with right colon cancer who undergo a right laparoscopic hemicolectomy and a antiperistaltic side-to-side ileocecal anastomosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>antiperistaltic side-to-side ileocecal anastomosis</intervention_name>
    <description>Right laparoscopic hemicolectomy + antiperistaltic side-to-side ileocecal anastomosis</description>
    <arm_group_label>Antiperistaltic anastomosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>isoperistaltic side-to-side ileocecal anastomosis</intervention_name>
    <description>Right laparoscopic hemicolectomy+isoperistaltic side-to-side ileocecal anastomosis</description>
    <arm_group_label>Isoperistaltic anastomosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has given informed consent to participate

          -  No surgery contraindications

          -  Elective surgery

          -  No pregnancy or nursery during the study

          -  Older than 18 years

          -  Complete preoperative cancer staging

          -  Tumour characteristics:

               -  Cecum, ascending, hepatic angle or transverse colon tumour confirmed by
                  endoscopic biopsy

               -  Radiologically resectable tumours

               -  Absence of vascular, nervous or bone infiltration

               -  T4 stages with near organ infiltration

               -  Absence of peritoneal carcinomatosis

               -  Absence of respiratory pathology that prevents for doing hydrogen breath test

        Exclusion Criteria:

          -  Pregnancy

          -  Intestinal bowel disease like Crohn's disease or ulcerative colitis.

          -  Metastatic bone illness

          -  Previous abdominal surgery with bowel resection

          -  Malabsorption syndromes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Lujan, Ph D</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Virgen de la Arrixaca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jesus Abrisqueta, Ph D.</last_name>
    <phone>+34 968 369677</phone>
    <email>j_abris@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Noelia Ib치침ez, MD</last_name>
    <phone>+34628443196</phone>
    <email>noelia.ibc@hotmail.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de La Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesus Abrisqueta, Ph D</last_name>
    </contact>
    <investigator>
      <last_name>Noelia Ib치침ez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Lujan, Ph D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <lastchanged_date>December 3, 2014</lastchanged_date>
  <firstreceived_date>November 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Virgen de la Arrixaca</investigator_affiliation>
    <investigator_full_name>Jesus Abrisqueta Carrion</investigator_full_name>
    <investigator_title>Ph D</investigator_title>
  </responsible_party>
  <keyword>Right hemicolectomy</keyword>
  <keyword>Side-to-side anastomosis</keyword>
  <keyword>Orocecal time</keyword>
  <keyword>Antipersitaltic</keyword>
  <keyword>Isoperistaltic</keyword>
  <keyword>Laparoscopic colectomy</keyword>
  <keyword>Right laparoscopic hemicolectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antidiarrheals</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
